Lack of trade mark evidence loses domain dispute
A company has lost a UDRP dispute after it failed to produce any evidence of its claimed trade mark licence for pharmaceuticals company Amgen’s mark Kineret
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: